Rockefeller Capital Management
HAE icon

Rockefeller Capital Management’s Haemonetics HAE Stock Holding History

Rockefeller Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.2K Buy
891
+13
+1% +$847 ﹤0.01% 3272
2025
Q4 		$70.4K Buy
878
+870
+10,875% +$58.5K ﹤0.01% 2903
2025
Q3 		$390 Buy
+8
New +$495 ﹤0.01% 4300
2023
Q1 		– Sell
-13
Closed -$1K – 2795
2022
Q4 		$1K Buy
+13
New +$1.04K ﹤0.01% 3689
2022
Q3 		– Sell
-386
Closed -$25K – 4079
2022
Q2 		$25K Buy
386
+333
+628% +$19.7K ﹤0.01% 2618
2022
Q1 		$3K Buy
53
+3
+6% +$163 ﹤0.01% 3501
2021
Q4 		$2K Sell
50
-3
-6% -$183 ﹤0.01% 3539
2021
Q3 		$3K Buy
53
+30
+130% +$1.89K ﹤0.01% 3341
2021
Q2 		$1K Sell
23
-7
-23% -$495 ﹤0.01% 3333
2021
Q1 		$3K Sell
30
-12
-29% -$1.49K ﹤0.01% 3020
2020
Q4 		$4K Buy
+42
New +$4.52K ﹤0.01% 2490
2019
Q4 		– Sell
-70
Closed -$9K – 2114
2019
Q3 		$9K Hold
70
– – ﹤0.01% 1454
2019
Q2 		$8K Buy
70
+50
+250% +$4.92K ﹤0.01% 1312
2019
Q1 		$2K Buy
+20
New +$1.82K ﹤0.01% 1786

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rockefeller Capital Management's HAE Position: Q1 2026 in Review

Rockefeller Capital Management increased its Haemonetics (HAE) stake by 1.5% in Q1 2026, buying an estimated $847 and bringing the position to 891 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3272.

Rockefeller Capital Management first reported a position in HAE in Q1 2019 and has held it in 14 quarters since. The position peaked at $70.4K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Rockefeller Capital Management held 891 shares of Haemonetics worth $50.2K as of Q1 2026.
  • Rockefeller Capital Management bought 13 Haemonetics shares in Q1 2026, an estimated $847.
  • Haemonetics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3272 holding.
  • Rockefeller Capital Management first reported a position in Haemonetics in Q1 2019 and has held it in 14 quarters since.
  • Rockefeller Capital Management's Haemonetics position peaked at $70.4K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.